世贸天阶制药

Beijing Shimao Tianjie Pharmaceutical Co., Ltd., also known as The Place Pharmaceutical, is a comprehensive pharmaceutical enterprise based in Beijing, China. The company was established through the restructuring of the former Beijing No. 4 Pharmaceutical Factory and is currently a core subsidiary of The Place Investment Group. It specializes in the research, development, and large-scale production of both chemical drugs and biological therapeutics. Shimao Tianjie is best known for its flagship biologic product, Aisheng (Recombinant Human Interleukin-2), which is widely used in immunotherapy for renal cell carcinoma and melanoma. Beyond oncology, the company maintains a robust portfolio of cardiovascular and anti-infective medications in various dosage forms, including injections and oral solids. The firm operates high-standard GMP-certified manufacturing facilities in the Beijing Economic-Technological Development Area to support its domestic commercial operations.